Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia
Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects...
Main Authors: | Mayur D. Mody MD, Deepak Ravindranathan MD, Harpaul S. Gill MD, Vamsi K. Kota MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-02-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709617690747 |
Similar Items
-
The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study
by: Vildan Özkocaman, et al.
Published: (2018-11-01) -
THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: G. A. Klyasova, et al.
Published: (2017-11-01) -
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia
by: Songji Tu, et al.
Published: (2023-11-01) -
Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey
by: Elif Gulsum Umit, et al.
Published: (2020-05-01) -
Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia
by: Simona De Gregori, et al.
Published: (2023-06-01)